Tech Mahindra and NVIDIA collaborate to advance drug safety with agentic solution
Tech Mahindra, a leading global provider of technology consulting and digital solutions to enterprises across industries, announced a pharmacovigilance (PV) autonomous solution built with NVIDIA AI software to advance drug safety management.
The transformative solution leverages agentic artificial intelligence (AI) and automation to enhance the accuracy, speed, and efficiency of pharmacovigilance processes, addressing critical industry challenges such as manual delays and data overload.
Powered by Tech Mahindra's TENO framework, which is built on NVIDIA's cutting-edge AI technology, the solution is designed to automate and optimise pharmacovigilance workflows. By integrating the NVIDIA AI Enterprise software platform, including NVIDIA NeMo™, NVIDIA NIM™ microservices, and NVIDIA AI Blueprints, the Tech Mahindra solution streamlines case intake, data transformation, quality control, and compliance management, thereby ensuring a seamless and intelligent PV workflow. Additionally, the LLM-powered AI agents within the solution autonomously handle case classification, prioritisation, and verification of pharmacovigilance emails to reduce the risk of human error.
Nikhil Malhotra, Chief Innovation Officer & Global Head of AI and Emerging Technologies Tech Mahindra, said, 'As the pharmaceutical industry navigates volumes of data during trials and post-launch, our collaboration with NVIDIA leverages generative AI and multi-agent systems to streamline pharmacovigilance process. Together, we are revolutionising drug safety management and using the innovative AI-driven framework to develop multiple use cases for our global customers'.
Tech Mahindra and NVIDIA work together to provide better patient outcomes by bringing agentic AI-driven intelligence to pharmacovigilance. The pharmacovigilance industry manages over 1,000 daily cases of adverse drug reaction (ADR) for major drugs. For instance, in the case of an email reporting adverse drug reaction (ADR), the AI-driven PV solution instantly flags, prioritises, and processes the request by eliminating human intervention that could potentially lead to delays and errors. The solution reduces turnaround times by up to 40%, enhances data accuracy by 30%, and cuts operational costs by 25%. This ensures timely case processing, regulatory adherence, and proactive risk mitigation, thereby transforming pharmacovigilance from reactive to predictive.
John Fanelli, Vice President, Enterprise Software, NVIDIA, said, 'AI is ideal for monitoring medicines throughout their lifecycle to support safety. Integrating AI into the Tech Mahindra TENO framework with NVIDIA AI Enterprise software enhances pharmacovigilance by augmenting human capabilities to help identify potential safety issues more effectively'.
Tech Mahindra has also expanded its TENO framework to encompass NVIDIA AI Enterprise, enriching it with customised AI agents to address a broad spectrum of industry challenges. The framework integrates NVIDIA NeMo™ to accelerate generative AI pipeline for data collection and curation, coupled with Tech Mahindra's VerifAI solution for data validation and governance. The distributed training and model customisation capabilities embedded within the framework ensure that the AI models continuously evolve to enhance decision-making precision.
Tech Mahindra is showcasing its solutions at NVIDIA GTC. For further information, please click here.
Image Credit: Tech Mahindra
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Emirates Woman
a day ago
- Emirates Woman
Lumena by Omniyat is the newest architectural wonder set to redefine workspaces in Dubai
Meet Lumena by OMNIYAT—the city's newest ultra-luxury commercial development and co-working space. Fresh off the success of Enara's headline-making debut, OMNIYAT has recently unveiled its most ambitious commercial statement yet: a 48-storey sculptural tower designed to be more than a workplace. With a targeted completion in 2029, Lumena is imagined as an icon of spatial innovation and biophilic design set to add to the Dubai skyline views and pave the way for future-forward ways of working. 'Lumena is the future of commercial real estate in Dubai. With its location, design, and integrated amenities, we are creating a new paradigm for commercial real estate that aligns with how the next generation of leaders wants to work and live. Leveraging technology, innovation, and future-proof design, LUMENA's sculpted form reflects both architectural brilliance and the effortless flow of ideas, ambition, and enterprise. This exceptional project reflects OMNIYAT's ongoing commitment to shaping the commercial landmarks of tomorrow,' says Mahdi Amjad, Founder and Executive Chairman at OMNIYAT. Architecturally, Lumena is striking with its slender profile featuring cantilevered forms and a multi-faceted facade. Inside, 91 meticulously designed shell-and-core office units, from full floors to boutique-scale spaces, offer flexible formats flooded with light and panoramic views. Natural materials, double-height glazing, and subtle textural cues bring an understated calm to the corporate domain. But what truly sets Lumena apart is its curation of amenities that rival luxury hotels. From the private-access Executive Club and Sky Pool to the wellness suite and Sky Theatre – a first for a commercial tower in Dubai – the environment is human-centric and the experience is anything but conventional. Concierge services extend to lifestyle bookings, wellness support, and even private shopping. Technologically, the tower is targeted to achieve Platinum status certifications across LEED, WELL Building™, WiredScore, and SmartScore, to make Lumena a global benchmark for sustainability and smart design. – For more on luxury lifestyle, news, fashion and beauty follow Emirates Woman on Facebook and Instagram Images: Supplied
Channel Post MEA
2 days ago
- Channel Post MEA
Infosys And Adobe Join Forces For AI-Driven Marketing Transformation
Infosys and Adobe have announced a strategic collaboration to jointly transform the marketing life cycle of global brands with AI. Together, they will bring capabilities from Infosys Aster and Adobe to unify customer experience at scale, personalize content to enable business growth while also streamlining workflows for efficiency. Infosys Aster is a set of AI-amplified marketing services, solutions and platforms that helps enterprises transform marketing into effective customer-champions and growth-partners. With creative services, experience design, digital commerce, MarTech orchestration, performance marketing and marketing operations, Infosys Aster brings AI-powered agility to the marketing value chain. Adobe empowers brands to deliver personalized, data-driven customer journeys across every touchpoint – combining content, data, and AI to create seamless, real-time experiences that drive loyalty and growth. Infosys CMO Radar 2024 revealed that AI-fluent CMOs are becoming a transformative force in business with 62 percent see their influence growing over broader corporate decisions. Together, Infosys and Adobe will orchestrate enterprise-grade marketing solutions, amplified by AI, that enables CMOs to: Deliver Unified Experiences at Scale. Marketers can deliver unified brand experiences, across channels, touchpoints, and personas, that are timely, relevant, and engaging regardless of scale. Adobe's Real-Time CDP and GenStudio enable effective content creation, segmentation, and experience delivery. Infosys Aster™ brings industry expertise and AI-amplified agility to marketing. This enables marketers to respond to changing customer behaviors, market trends, and business needs while orchestrating unified brand experiences across customers, channels, and markets. For example, a communication service provider used Adobe Marketing Cloud with Infosys Aster™ services to deliver in-app experiences and custom-target offers to millions of customers that were also amplified with matching multi-channel promotions. Digital engagement soared by 40 percent. Personalize Content to Catalyze Growth. Launching hyper-targeted personalized campaigns across markets and segments with localized, scalable content strategies will be easier. With Adobe technologies, brands can deliver personalized content, drive real-time promotion and pricing based on customer behavior and cross-channel engagement insights. Infosys Aster helps create a shared digital foundation, by integrating MarTech and enterprise systems – crucial for optimizing the content delivery strategy. For example, a retail jewelry brand developed a personalized campaign with Adobe Experience Platform and Adobe Journey Optimizer and then harnessed Infosys Aster to create immersive experiences with dynamic 3D modelling and optimize content delivery. The result was a 27 percent improvement in campaign performance. Streamline Workflows for Efficiency. The integrated solution brings autonomous agents to plan, execute and optimize marketing tasks and workflows. With Infosys Aster's AI-powered orchestration of Adobe technologies, marketers can automate content creation, streamline campaign workflows, improve channel efficiency, and increase campaign efficacy. A technology giant, for example, rebuilt their MarTech core with Adobe digital marketing solutions along with customer 360° views and analytics from Infosys Aster improving their workflows, and driving up campaign go-live efficiencies by 20 percent. 'AI, for marketing, has very quickly evolved from productivity- and creativity-amplifier to a true navigator for marketers. CMOs know that AI can be their partner in propelling business growth while helping them navigate the complexities of scaling deeply personalized content and simultaneously unifying the brand experience,' said Sumit Virmani, EVP and Global Chief Marketing Officer, Infosys. 'This joint offering is integral to the customer experience personalization approach that we are driving at Infosys, and is positioned to be a foundational capability for CMOs to drive the growth-focused marketing they've always aspired to.' Infosys Aster AI-amplified marketing suite and Adobe solutions uniquely enable the CMO to partner with the CIO to advocate for customer-first, AI-first experiences, and marketing. The integrated solution leads the way with a 'responsible by design' approach to AI practices that strengthen brand integrity and foster trust with customers. 'In an attention-based economy where consumers and businesses are inundated with content across every channel, impactful creative personalized at scale is what will enable marketers to break through,' said Anil Chakravarthy, President, Digital Experience Business, Adobe. 'Adobe and Infosys are bringing together creativity, marketing and AI innovations to transform Customer Experience Orchestration, streamlining the creation and delivery of compelling experiences across every touchpoint and channel.' Douglas Hayward, Senior Research Director, Worldwide Customer Experience Services and Strategies, IDC, said, 'Today's CMOs need AI-enabled tools that understand consumers and business customers as individuals with context-specific needs, creating personalized on-brand offerings and messages that generate value for brand and customer alike. To drive sustainable value for both the brand and its customers, CMOs must plan, deploy and manage these tools rigorously across the entire customer lifecycle. That requires a new generation of AI-native marketing tools and services from both software makers and marketing services companies. This collaboration between Infosys Aster and Adobe aims to accelerate marketing excellence with AI and is in the right direction to address customer needs.'
Tahawul Tech
2 days ago
- Tahawul Tech
SandboxAQ improves drug discovery with data creation
SandboxAQ, an artificial intelligence startup, recently released a wealth of data in hopes it will speed up the discovery of new medical treatments. The goal is to help scientists predict whether a drug will bind to its target in the human body. But while the data is backed up by real-world scientific experiments, it did not come from a lab. Instead, SandboxAQ, which has raised nearly $1 billion in venture capital, generated the data using Nvidia's chips and will feed it back into AI models that it hopes scientists can use to rapidly predict whether a small-molecule pharmaceutical will bind to the protein that researchers are targeting, a key question that must be answered before a drug candidate can move forward. For example, if a drug is meant to inhibit a biological process like the progression of a disease, scientists can use the tool to predict whether the drug molecule is likely to bind to the proteins involved in that process. The approach is an emerging field that combines traditional scientific computing techniques with advancements in AI. In many fields, scientists have long had equations that can precisely predict how atoms combine into molecules. But even for relatively small three-dimensional pharmaceutical molecules, the potential combinations become far too vast to calculate manually, even with today's fastest computers. So SandboxAQ's approach was to use existing experimental data to calculate about 5.2 million new, 'synthetic' three-dimensional molecules – molecules that haven't been observed in the real world, but were calculated with equations based on real-world data. That synthetic data, which SandboxAQ is releasing publicly, can be used to train AI models that can predict whether a new drug molecule is likely to stick to the protein researchers are targeting in a fraction of the time it would take to calculate it manually, while retaining accuracy. SandboxAQ will charge money for its own AI models developed with the data, which it hopes will get results that rival running lab experiments, but virtually. 'This is a long-standing problem in biology that we've all, as an industry, been trying to solve for', said Nadia Harhen, general manager of AI simulation at SandboxAQ. 'All of these computationally generated structures are tagged to a ground-truth experimental data, and so when you pick this data set and you train models, you can actually use the synthetic data in a way that's never been done before'. Source: Reuters Image Credit: Stock Image
